<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: elsevier</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'elsevier'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22elsevier%22&t=%22elsevier%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:10:52 +0100</lastBuildDate>
        <item>
            <title>Mosby’s Pocketbook of Mental Health</title>
            <link>http://www.medworm.com/index.php?rid=4394448&amp;cid=t_129724_88_f&amp;fid=38129&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2FbHJDOfP3Pcs%2F</link>
            <description>LITFL book review of Mosby's Pocketbook of Mental Health (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4394448</comments>
            <pubDate>Tue, 25 Jan 2011 08:00:31 +0100</pubDate>
            <guid isPermaLink="false">4394448</guid>        </item>
        <item>
            <title>Toxicology Handbook</title>
            <link>http://www.medworm.com/index.php?rid=4133720&amp;cid=t_129724_88_f&amp;fid=38129&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2FMGbS78WUR6o%2F</link>
            <description>The Life in the Fast lane team have had great fun putting together blog posts, interrogative questions, clinical cases, frivolous trivia and putting our slant on the evidence behind emergency medicine literature. However, as well as the blog writing there has been a little bit of book writing and it is exciting to see the final stages drawing toward 'closure' on the four books completed this year. (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4133720</comments>
            <pubDate>Wed, 03 Nov 2010 12:37:56 +0100</pubDate>
            <guid isPermaLink="false">4133720</guid>        </item>
        <item>
            <title>Midwifery Preparation for Practice</title>
            <link>http://www.medworm.com/index.php?rid=4133722&amp;cid=t_129724_88_f&amp;fid=38129&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2Fe3xgdF3DX6w%2F</link>
            <description>Midwifery preparation to practice facilitates the maternity care provider to explore all care options to empower women throughout their pregnancy, to make informed decision regarding their care. This is demonstrated within the book by recent evidence based research findings. (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4133722</comments>
            <pubDate>Wed, 03 Nov 2010 02:00:46 +0100</pubDate>
            <guid isPermaLink="false">4133722</guid>        </item>
        <item>
            <title>Clinical Neurology a primer</title>
            <link>http://www.medworm.com/index.php?rid=4040569&amp;cid=t_129724_88_f&amp;fid=38129&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2F-1AhpKdt5m0%2F</link>
            <description>Book Review on Clinical Neurology a primer, written by neurologist Dr Peter Gates. (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4040569</comments>
            <pubDate>Thu, 07 Oct 2010 04:56:05 +0100</pubDate>
            <guid isPermaLink="false">4040569</guid>        </item>
        <item>
            <title>In Medical Publishing, Is Disclosure Enough?</title>
            <link>http://www.medworm.com/index.php?rid=2660944&amp;cid=t_129724_150_f&amp;fid=34889&amp;url=http%3A%2F%2Fpharmamkting.blogspot.com%2F2009%2F07%2Fin-medical-publishing-is-disclosure.html</link>
            <description>&quot;Full disclosure&quot; (aka, &quot;transparency&quot;) is a term used so often these days that it is becoming meaningless or at least so transparent as to be invisible.A case in point is the brouhaha regarding Elsevier's publication of &quot;fake&quot; medical journals in Australia, which is seemingly another hotbed for pharmaceutical marketing excess.It has been said that Elsevier &quot;colluded with Merck to produce a fake journal, the Australasian Journal of Bone and Joint Medicine (AJBJM) to promote rofecoxib and other Merck products.&quot; That's how critics described it in correspondence to The Lancet -- a real medical journal published by Elsevier. The authors call for Elsevier to either divest itself of of either its medical publishing or pharmaceutical services division (see here).Elsevier admits it should not have...</description>
            <author>Pharma Marketing Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2660944</comments>
            <pubDate>Fri, 31 Jul 2009 11:34:00 +0100</pubDate>
            <guid isPermaLink="false">2660944</guid>        </item>
        <item>
            <title>Peer recognition and building relationships - Even in drug design</title>
            <link>http://www.medworm.com/index.php?rid=2424171&amp;cid=t_129724_107_f&amp;fid=36698&amp;url=http%3A%2F%2Fminingdrugs.blogspot.com%2F2009%2F05%2Fpeer-recognition-and-building.html</link>
            <description>&quot;Experts will want to contribute to coworkers who need them, who will hear them, who will respect them and who may even thank them. ... Rather than asking, How do we incentivise people to share their knowledge? It would be more useful to ask, How do we develop relationships across the globe that will set in motion more knowledge sharing?&quot; [slightly generalized after Nancy Dixon]&quot;Today there seems to be a new distribution model that is emerging.  One that is based on people’s ability to publically syndicate and distribute messages — aka content — in an open manner.  This has been a part of the internet since day one — yet now its emerging in a different form — it's not pages, it's streams, its social and so its syndication.&quot; [John Borthwick]Recently, there are many efforts ongoing...</description>
            <author>Mining Drug Space</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2424171</comments>
            <pubDate>Tue, 19 May 2009 19:16:00 +0100</pubDate>
            <guid isPermaLink="false">2424171</guid>        </item>
        <item>
            <title>Misconduct roundup 12 May 09</title>
            <link>http://www.medworm.com/index.php?rid=2406167&amp;cid=t_129724_150_f&amp;fid=36939&amp;url=http%3A%2F%2Fscientific-misconduct.blogspot.com%2F2009%2F05%2Fmisconduct-roundup-12-may-09.html</link>
            <description>I am going to try to make this a regular feature. Here are a few items of note:Professor Chris Gillberg, scientific misconduct and a problematical academic appointmentProfessor Christopher Gillberg is now in possession of an honorary Professorship and joins the staff list at University College London (UCL) and at Great Ormond Street Hospital for Children (see here). Gillberg, you will recall, is the scientist who headed the Swedish team that destroyed hundreds of thousands of pages of raw clinical research data after being asked to explain anomalies in their findings. The destruction took place in the face of a pending research misconduct examination. To make matters worse, Gillberg's supporters blamed scientologists for somehow causing the problem and supporters may have attempted to inti...</description>
            <author>Scientific Misconduct Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2406167</comments>
            <pubDate>Tue, 12 May 2009 17:59:00 +0100</pubDate>
            <guid isPermaLink="false">2406167</guid>        </item>
        <item>
            <title>Merck’s Ghostwriters, Haunted Papers and Fake Elsevier Journals</title>
            <link>http://www.medworm.com/index.php?rid=2398545&amp;cid=t_129724_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F05%2F08%2Fmercks-ghostwriters-haunted-papers-and-fake-elsevier-journals%2F</link>
            <description>What is the purpose of publications? (&amp;#8230;) The purpose of data is to support, directly or indirectly, the marketing of our product.” [1, 2]
It is well known that studies with significant positive results are easier to find than those with &amp;#8216;negative&amp;#8217; results. This so called publication bias can arise from the tendency to submit or [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2398545</comments>
            <pubDate>Fri, 08 May 2009 02:41:13 +0100</pubDate>
            <guid isPermaLink="false">2398545</guid>        </item>
        <item>
            <title>Bridging chemistry islands to the web data silo</title>
            <link>http://www.medworm.com/index.php?rid=2286141&amp;cid=t_129724_107_f&amp;fid=36698&amp;url=http%3A%2F%2Fminingdrugs.blogspot.com%2F2009%2F03%2Fbridging-chemistry-islands-to-web-data.html</link>
            <description>Triggered by a few announcements of major publishers and web-services I could not resist to create a little chemical-web 2.0-story.Bridging Chemistry IslandsView more presentations from Joerg kurt Wegner. (Source: Mining Drug Space)</description>
            <author>Mining Drug Space</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2286141</comments>
            <pubDate>Sun, 22 Mar 2009 15:04:00 +0100</pubDate>
            <guid isPermaLink="false">2286141</guid>        </item>
        <item>
            <title>MedConnect - Where Medicine Connects?</title>
            <link>http://www.medworm.com/index.php?rid=2212631&amp;cid=t_129724_88_f&amp;fid=38129&amp;url=http%3A%2F%2Fsandnsurf.medbrains.net%2F2009%2F02%2Fmedconnect-where-medicine-connect%2F</link>
            <description>Elsevier Australia has long been associated with publishing textbooks and journals for the Australian and New Zealand markets. Until recently, the Australasian arm of the Elsevier publishing giant had been content with their role as &amp;#8216;hard copy&amp;#8217; publishers of high quality health related literature, leaving the internet and software based platforms to their US counterparts.
However [...] (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2212631</comments>
            <pubDate>Wed, 25 Feb 2009 10:51:17 +0100</pubDate>
            <guid isPermaLink="false">2212631</guid>        </item>
        <item>
            <title>Ed Silverman Moves on From Pharmalot, Joins Elsevier</title>
            <link>http://www.medworm.com/index.php?rid=2081065&amp;cid=t_129724_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F01%2F05%2Fed-silverman-moves-on-from-pharmalot-joins-elsevier%2F</link>
            <description>Pharmalot is a blog we turned to when we wanted to keep up-to-date on the latest pharmaceutical news or scandal. Written for the past 2 years by Ed Silverman, he&amp;#8217;s decided to move on to take a job over at Elsevier and may very well start blogging for them on the same topics (either at the In Vivo blog or some other company blog).
	While we&amp;#8217;ll miss Pharmalot as it exists today, we hope to see Ed Silverman continue on in the tradition he started more than 2 years ago, breaking interesting stories about the pharmaceutical industry. We can&amp;#8217;t imagine the blogosphere being the same without him.
	Read the full article: Pharmalot, R.I.P.; Long Live, Ed Silverman (Source: World of Psychology)</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2081065</comments>
            <pubDate>Tue, 06 Jan 2009 01:43:20 +0100</pubDate>
            <guid isPermaLink="false">2081065</guid>        </item>
        <item>
            <title>Eugene Koonin direct</title>
            <link>http://www.medworm.com/index.php?rid=2061437&amp;cid=t_129724_132_f&amp;fid=35624&amp;url=http%3A%2F%2Fsuicyte.wordpress.com%2F2008%2F12%2F23%2Feugene-koonin-direct%2F</link>
            <description>I have just read the blog post by Derek Lowe &amp;#8216;Publishing your work the Easy Way&amp;#8216;, which covers the case of M.S. El Naschie, who is Editor-in-Chief of the journal Chaos, Solitons &amp; Fractals and apparently uses this position to publish tons of his own papers in that journal. Nature has also covered this case before, where it has been said that the papers are mostly of poor quality and that El Naschie might also have &amp;#8216;improved&amp;#8217; his CV by using a wrong affiliation to a respectable institute. I am neither an expert on solitons or fractals (chaos maybe, if you consider the state of my desktop) and I am clearly not the one to  judge the quality of El Naschie&amp;#8217;s contributions. Check here for some scientific details.
Reading about this story made me think about how...</description>
            <author>Suicyte Notes</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2061437</comments>
            <pubDate>Tue, 23 Dec 2008 00:31:13 +0100</pubDate>
            <guid isPermaLink="false">2061437</guid>        </item>
        <item>
            <title>Medical Publisher Investigates Ghostwriting Charge</title>
            <link>http://www.medworm.com/index.php?rid=2056344&amp;cid=t_129724_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F490526529%2F</link>
            <description>Elsevier is investigating the widely publicized allegation by the US Senate Finance Committee that one of its journals published an article on hormone replacement therapy that was improperly ghostwritten by Wyeth, which was promoting its Prempro med, The New York Times writes.
Earlier this month, Chuck Grassley, the ranking Republican on the committee, raised questions about the May 2003 &amp;#8220;Editors&amp;#8217; Choice&amp;#8221; article in The American Journal of Obstetrics and Gynecology. The article, signed by John Eden, an associate professor at the University of New South Wales, was among articles Grassley cited that were favorable to Wyeth drugs (back story).
Grassley charged Wyeth commissioned the articles and had them ghostwritten by a medical writing firm called DesignWrite, but only aft...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2056344</comments>
            <pubDate>Sun, 21 Dec 2008 14:19:49 +0100</pubDate>
            <guid isPermaLink="false">2056344</guid>        </item>
        <item>
            <title>Cancer Drug Compendium Violates CMS Guidelines</title>
            <link>http://www.medworm.com/index.php?rid=1451974&amp;cid=t_129724_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F293531036%2F</link>
            <description>Medicare is nearing approval of three additional drug compendia that can be used to justify reimbursement for off-label use of cancer drugs, including one that violates agency guidelines on conflict-of-interest disclosure, according to Integrity in Science Watch.
The National Comprehensive Cancer Network’s Drugs and Biologics Compendium, which is drawn from its Clinical Practice Guidelines, fails to disclose corporate ties of the 20 to 24 experts who sit on its 44 guideline-writing panels. Instead, it lists all the companies which gave money or research support to any committee member without listing any specific member or the amount given, ISW writes.
In 2006, the Medicare Evidence Development and Coverage Advisory Committee recommended that any new compendia approved by the Center for ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1451974</comments>
            <pubDate>Mon, 19 May 2008 14:13:06 +0100</pubDate>
            <guid isPermaLink="false">1451974</guid>        </item>
        <item>
            <title>Wiser Wiki ; A medical wiki site</title>
            <link>http://www.medworm.com/index.php?rid=2523023&amp;cid=t_129724_97_f&amp;fid=34618&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmHouse%2F%7E3%2FXAH_mnnFsxA%2Fwiser-wiki-medical-wiki-site.html</link>
            <description>Elsevier has launched a medical wiki website, in similar lines to the acclaimed wikipedia. This wiki site will be catering to the needs of Practicing Physicians and students. There is a need for a platform for medical personnel to collaborate and contribute medical information.WiserWiki is a wiki that will allow accredited physicians to comment, collaborate and update medical information online and is viewable by everyone. The site was originally seeded with content from John Noble’s “Textbook of Primary Care Medicine” (3rd Edition).Wiserwiki is online currently in its beta version. The provisions of registering and editing the contents are restricted only to the registered medical practitioners. Such restrictions make the contents more authentic and reliable.We congratulate the Else...</description>
            <author>Pharm House</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2523023</comments>
            <pubDate>Mon, 19 Nov 2007 11:12:00 +0100</pubDate>
            <guid isPermaLink="false">2523023</guid>        </item>
        <item>
            <title>Elsevier’s Approaches to Public Access of Biomedical and Cancer Research</title>
            <link>http://www.medworm.com/index.php?rid=1005596&amp;cid=t_129724_107_f&amp;fid=36585&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHighlightHealth%2F%7E3%2F180099754%2F</link>
            <description>This article was published on Highlight HEALTH. (Source: Highlight HEALTH)</description>
            <author>Highlight HEALTH</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1005596</comments>
            <pubDate>Mon, 05 Nov 2007 15:59:50 +0100</pubDate>
            <guid isPermaLink="false">1005596</guid>        </item>
        <item>
            <title>Small steps but a long way to go</title>
            <link>http://www.medworm.com/index.php?rid=716630&amp;cid=t_129724_132_f&amp;fid=35011&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fmndoci%2F%7E3%2F130677495%2F</link>
            <description>Elsevier now allows Google to crawl content from most of its family of journals. That this was not yet the case is a shame, since scientific literature that cannot be crawled is worthless. Hopefully this means that over time Elsevier will open up access to its journals some more.
Technorati Tags: Google, Elsevier, Open Science, Open Access (Source: business|bytes|genes|molecules)</description>
            <author>business|bytes|genes|molecules</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=716630</comments>
            <pubDate>Thu, 05 Jul 2007 07:26:16 +0100</pubDate>
            <guid isPermaLink="false">716630</guid>        </item>
    </channel>
</rss>

